U.S. Markets closed

Top Insider Buys Highlight

- By Shuda Xia

The largest insider buys over the past week were Fidelity National Information Services Inc. (FIS), Elanco Animal Health Inc. (ELAN), Alkermes PLC (ALKS) and MDU Resources Group Inc. (MDU).

Fidelity National director bought 5,075 shares

Director Alexandar Navab Jr. bought 5,075 shares of Fidelity National on March 21 for an average price of $107.22 per share. The share price has increased 2.98% since then.


A component of the S&P 500, Fidelity National is an international financial services and technology company that focuses on providing payment processing and banking software and services. The company has a market capitalization of $35.68 billion; as of March 22, it traded around $110.41.

On Feb. 12, the company reported full-year and fourth-quarter 2018 results. Revenue for the year decreased 2.8% to $8.423 billion. Operating income grew to $1.458 billion, while the operating income margin expanded 80 basis points to 17.3%.

Elanco Animal Health director bought 20,000 shares

Director David R. Hoover bought 20,000 shares of Elanco on March 13 for an average price of $31.43 per share. Since then, the share price has gained 4.01%.

Elanco is an American international animal health and animal food production company that sells its products and services in over 90 countries. The company has a market capitalization of $11.95 billion; as of March 22, it traded at $32.69.

On March 13, the company announced the appointment of four new members to its board of directors. The new members will serve on staggered terms, creating a new nine-member board. The appointments follow Eli Lilly's (LLY) full divestiture of Elanco, making it a fully independent company.

Alkermes director bought 4,302 shares

Director Nancy Wysenski bought 4,302 shares of Alkermes on March 14 for an average price of $33.09 per share. The share price since then has risen 2.63%.

Alkermes is an Irish biopharmaceutical company that focuses on developing drugs to treat central nervous system diseases. The company is a component of the Russell 1000. It has a market capitalization of $5.3 billion; as of March 22, it traded at $33.96.

On Feb. 26, Alkermes announced the initiation of ARTISTRY-2, a new clinical study of ALKS 4230 administered subcutaneously as monotherapy and in combination with the PD-1 inhibitor KEYTRUDA in patients with advanced solid tumors. The study aims to explore the safety and efficacy of ALKS 4230 and assess potential dosing schedules.

MDU Resources director bought 3,000 shares

Director David M. Sparby bought 3,000 shares of MDU on March 14 for an average price of $25.75 per share. The share price has fallen 0.89% since then.

MDU Resources is an American energy delivery, natural gas and construction company. Its electric and natural gas utility companies serve approximately 1.1 million customers across 48 U.S. states. The company has a market capitalization of $5 billion; as of March 22, it traded at $25.52.

On March 4, MDU Resources announced its subsidiary, Knife River Corp., acquired Viesko Redi-Mix Inc., a ready-mix concrete supplier. The acquisition complements Knife River's existing Oregon operations and provides expansion for the company into the Portland Metro and Willamette Valley markets.

For the complete list of stocks bought by company executives, go to Insider Trades.

Disclosure: I do not own stock in any of the companies mentioned in the article.

This article first appeared on GuruFocus.